Nahad Wassel, DPM
Foot & Ankle Surgery · Las Vegas, NVNPI 1033593843
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Goode Surgical Inc at 34.3% of the total. Reporting peaked in 2019 at $10,616 and has fallen 95.4% since, to $485 in 2025.
Across 284 payments — averaging $85.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$8K
- Smith+Nephew$5K
- Biotissue Holdings Inc.$3K
- Arthrex$3K
- Stryker$1K
- Forte Bio-pharma LLC$488
- plus $3K from 29 others
What the payments were for
- Speaking & faculty fees$1,0004%
- Travel & lodging$2,62011%
- Food & beverage$12,93453%
- Education$7,76732%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 27 | $8,331 |
| Smith+Nephew | 101 | $4,717 |
| Biotissue Holdings Inc. | 48 | $3,353 |
| Arthrex | 22 | $3,335 |
| Stryker(2 entities) | 19 | $1,054 |
| Forte Bio-pharma LLC | 3 | $488 |
| Organogenesis Inc. | 8 | $470 |
| Osiris Therapeutics Inc. | 5 | $282 |
| Shockwave Medical, Inc | 1 | $224 |
| Abyrx, Inc | 1 | $202 |
| Nevro Corp. | 3 | $201 |
| Bioventus LLC | 7 | $186 |
| Pinnacle Transplant Technologies, LLC | 1 | $165 |
| Kerecis Limited | 3 | $154 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $152 |
| Acera Surgical, Inc. | 1 | $149 |
| Arthrosurface Incorporated | 2 | $145 |
| Metric Medical Devices, Inc. | 1 | $96 |
| Melinta Therapeutics, LLC | 4 | $91 |
| Zyla Life Sciences, Inc. | 5 | $77 |
| Penumbra, Inc. | 1 | $63 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| AbbVie | 2 | $46 |
| X-spine Systems, Inc. | 1 | $44 |
| Solventum Corporation | 2 | $38 |
| Merck | 2 | $30 |
| Averitas Pharma Inc. | 2 | $29 |
| Aroa Biosurgery Incorporated | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $24 |
| Medtronic | 1 | $19 |
| Cardiovascular Systems Inc. | 1 | $18 |
| Amgen | 1 | $18 |
| KCI USA, Inc. | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$2,069
- GRAFIX PL$1,873
- NEOX$1,598
- CLARIX$1,598
- Prolate$734
- Grafix$697
- Grafix PL PRIME$503
- Nalocet$456
- Grafix XC$233
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$224
- GrafixPL$222
- Montage Settable Resorbable Hemostatic Bone Putty$202
- PuraPly$185
- ASNIS$161
- Restrata Wound Matrix$149
- PICO$138
- RENASYS GO v2 HOME$138
- Omnia$138
- STRAVIX PL$123
- RENASYS GO$121
How this compares
$24,321 in reported general payments places this provider in the 85th percentile of 84 foot & ankle surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 68 | $2,139 |
| Mupirocin | 72 | $1,445 |
| Ammonium Lactate | 30 | $498 |
| Gabapentin | 17 | $396 |
| Methylprednisolone | 37 | $152 |
| Cephalexin | 36 | $130 |
| Triamcinolone Acetonide | 12 | $115 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $47 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Las Vegas
- Troy WatsonLas Vegas$1.2M
- Ira WeinerLas Vegas$135K
- Abdolreza RaissiLas Vegas$110K
- Anthony BorgiaLas Vegas$47K
- Casey BurchillLas Vegas$20K
- Timothy BrookesLas Vegas$14K
- Daniel HallmanLas Vegas$12K
- Grant BeckLas Vegas$10K
- Thomman KuruvillaLas Vegas$9K
- Blair HendershotLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.